MENU
ROIV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Roivant Sciences (ROIV) Ownership - Who owns Roivant Sciences?

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more

Profile

Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.37B
P/E Ratio
1.97
Total Cash
4.39B
Projected Growth
N/A
Total Debt
98.85M
Revenue
20.33M
Risk (Beta)
0.23
Dividend Yield
N/A
Total Cash/Share
6.31
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price

Fundamentals

ROIV
Capitalization
15.4B
P/E Ratio
1.97
Risk (Beta)
0.23
Dividend Yield
N/A
Total Cash
4.39B
Total Cash/Share
6.31
Total Debt
98.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
20.3M
ROE
N/A
Book Value
4.36B
P/B Ratio
3.52
Cash Flow
N/A
Earnings
-0.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
33.70
Current Revenue Per Employee
2094.67
Dividends Per Share - Security
N/A
EBITDA
-1.14B
Float
N/A
Float - Current
N/A
Gross Income Margin
92.93
Revenue To Assets
-6.64
Shares Held By Institutions
15.5B
Shares Outstanding - Current
695M
Total Liabilities
257M
Total Volume MTD
N/A
Value
-1
Gain YTD
80.389
View a ticker or compare two or three
ROIV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ROIV showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A